Heather Brianne Dixon - 29 Mar 2023 Form 4 Insider Report for Signify Health, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 29 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Mar 2023, 08:58:27 UTC
Prior SEC filing: 03 Mar 2023
Next SEC filing: 16 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Adam McAnaney, as attorney-in-fact for Heather Brianne Dixon

Key filing fact

Heather Brianne Dixon filed Form 4 for Signify Health, Inc. on 29 Mar 2023.

Key facts

This page summarizes Heather Brianne Dixon's Form 4 filing for Signify Health, Inc..
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 29 Mar 2023, 08:58.

Change

Previous filing in this sequence was filed on 03 Mar 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGFY transaction

Class A Common Stock

Disposed to Issuer

Transaction value
Shares: -14,672
Change %: -49%
Price
Shares after: 15,002
Date: 29 Mar 2023
Ownership: Direct
Footnotes: F1

SGFY transaction

Class A Common Stock

Disposed to Issuer

Transaction value
Shares: -15,002
Change %: -100%
Price
Shares after: 0
Date: 29 Mar 2023
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Heather Brianne Dixon is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU.

Footnote F2

Pursuant to the Merger Agreement, each share of Class A Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled and converted into the right to receive the Per Share Consideration.